Delivery Order SPE2DB20D2104-SPE2DB24FS94H
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,932.85 delivery order is for the supply of Naloxone 2 mg/2 ml syringes, which are critical medical supplies used to treat opioid overdoses. The contract has an ultimate completion date of April 17, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an extensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,651.89 firm fixed-price delivery order is for the supply of 4,566,399,963 units of 2 mg/2 mL naloxone syringes. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award is for the delivery of 4,565,058,079 units of the naloxone 2 mg/2 ml syringe 2 ml to the U.S. Defense Department's Medical Supply Chain. The contract was awarded to the corporate office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The firm-fixed-price delivery order has a ceiling value of $3,293.72 and an ultimate completion date of July 3, 2024. The contract is not set aside and was awarded directly by the Defense Logistics...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,946.41, is for the provision of 2 mg/2 ml naloxone syringes. The contract is a firm fixed-price Delivery Order with no set-aside designation, meaning it was open to full and open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Naloxone 2 mg/2 ml syringes, with a ceiling value of $1,224.45 and a period of performance through June 12, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corporation holds a...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,351.25 firm fixed-price Delivery Order is for the supply of 2 mg/2 mL naloxone syringes, a critical medication used to reverse opioid overdoses. The contract has a June 2023 completion date and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen holds a $999,999,999...
- This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $2,527.15, is for the delivery of Naloxone 2 mg/2 ml syringes to an unspecified location. It is a firm fixed-price delivery order contract with the Defense Logistics Agency (DLA) Troop Support Medical under the agency's primary Indefinite Delivery Contract (IDC) with Amerisourcebergen, valued up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,558,945,946 units of Naloxone 2 mg/2 mL syringes. The contract has a firm fixed price of $1,077.89 and a completion date of November 2, 2022. The contract is a delivery order and was not subject to any set-aside requirements. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,102.89 firm fixed-price delivery order contract is for the supply of 4 mg naloxone hydrochloride nasal spray. The contract has an ultimate completion date of August 5, 2024 and was awarded on August 2, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- The Defense Logistics Agency awarded a $2,159.74 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Naloxone 2 mg/2 mL syringes. The contract is a firm fixed price delivery order with a completion date of September 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made through competitive procurement with no set-aside designation, reflecting the vendor's capability to meet federal medical...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS94HDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.19 firm fixed-price delivery order is for the supply of naloxone 2 mg/2 ml syringes. The contract has an ultimate completion date of March 11, 2024 and was awarded on March 8, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. There is no set-aside designation noted for this specific delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 3/8/24 |